ArticlePharmaceuticals (Basel, Switzerland)2026

Discovery and Evaluation of Novel Calenduloside E Derivatives Targeting HSP90β in Ox-LDL-Induced HUVECs Injury.

Fang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.